Gallbladder cancer laboratory tests: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Laboratory findings consistent with the diagnosis of gallbladder [[cancer]] include abnormal [[liver function tests]] and elevated [[CA 19-9]] and [[CEA]] levels. | |||
==Laboratory tests== | |||
Transabdominal ultrasound, CT scan, endoscopic ultrasound, MRI, and MR cholangio-pancreatography (MRCP), [[CEA]], [[CA 19-9]], [[liver function tests]] can be used for diagnosis. A biopsy is the only certain way to tell whether the tumorous growth is malignant or not | |||
Transabdominal ultrasound, CT scan, endoscopic ultrasound, MRI, and MR cholangio-pancreatography (MRCP) can be used for diagnosis. A biopsy is the only certain way to tell whether the tumorous growth is malignant or not | |||
==References== | ==References== |
Revision as of 13:39, 25 August 2015
Gallbladder cancer Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Gallbladder cancer laboratory tests On the Web |
American Roentgen Ray Society Images of Gallbladder cancer laboratory tests |
Risk calculators and risk factors for Gallbladder cancer laboratory tests |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Laboratory findings consistent with the diagnosis of gallbladder cancer include abnormal liver function tests and elevated CA 19-9 and CEA levels.
Laboratory tests
Transabdominal ultrasound, CT scan, endoscopic ultrasound, MRI, and MR cholangio-pancreatography (MRCP), CEA, CA 19-9, liver function tests can be used for diagnosis. A biopsy is the only certain way to tell whether the tumorous growth is malignant or not
References